Systems Immunogerontology Linking Immunosenescence and Inflammaging to Translational Interventions

Immune aging involves interacting changes in host defense and inflammatory regulation rather than uniform functional decline. This narrative review examines immunosenescence and inflammaging as mutually reinforcing processes and evaluates the evidence for interventions that might interrupt their feedback. We discuss thymic involution, T-cell differentiation and dysfunction, cytomegalovirus-associated repertoire remodeling, myeloid-biased hematopoiesis, B-cell regulatory defects, and tissue- and sex-associated heterogeneity in innate immunity. Expanded consideration is given to the senescence-associated secretory phenotype, mitochondrial damage, nutrient excess, and impaired clearance as drivers of chronic inflammation. We distinguish organism-level immunosenescence from cellular senescence and separate human observations from experimental mechanisms. Inflammatory clocks, including iAge and ipAGE, and immunoglobulin G glycosylation measures offer research tools for characterizing biological heterogeneity, but their clinical decision thresholds and validity as treatment-response surrogates remain uncertain. Translational evidence ranges from small, uncontrolled senolytic and thymic-regeneration studies to randomized trials of mTOR inhibition and established efficacy of adjuvanted zoster vaccination. Negative trial findings and limitations of biomarker-based rejuvenation claims are considered. The central objective is to preserve protective immunity while reducing persistent inflammation; demonstrating durable improvements in clinical outcomes remains essential before experimental approaches can be regarded as immune rejuvenation therapies.

Authors

Institutions

Publication Details

Journal
Cells
Published
2026-11-17
DOI
https://doi.org/10.3390/cells15222100
Primary Topic
Telomeres, Telomerase, and Senescence
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Systems Immunogerontology Linking Immunosenescence and Inflammaging to Translational Interventions

Daniel Paredes, David Bar‐Or, Jason S. Williams, Isaac Melamed
2 links
Cells
Telomeres, Telomerase, and Senescence
article

Systems Immunogerontology Linking Immunosenescence and Inflammaging to Translational Interventions

Daniel Paredes, David Bar‐Or, Jason S. Williams, Isaac Melamed
article en

Abstract

Immune aging involves interacting changes in host defense and inflammatory regulation rather than uniform functional decline. This narrative review examines immunosenescence and inflammaging as mutually reinforcing processes and evaluates the evidence for interventions that might interrupt their feedback. We discuss thymic involution, T-cell differentiation and dysfunction, cytomegalovirus-associated repertoire remodeling, myeloid-biased hematopoiesis, B-cell regulatory defects, and tissue- and sex-associated heterogeneity in innate immunity. Expanded consideration is given to the senescence-associated secretory phenotype, mitochondrial damage, nutrient excess, and impaired clearance as drivers of chronic inflammation. We distinguish organism-level immunosenescence from cellular senescence and separate human observations from experimental mechanisms. Inflammatory clocks, including iAge and ipAGE, and immunoglobulin G glycosylation measures offer research tools for characterizing biological heterogeneity, but their clinical decision thresholds and validity as treatment-response surrogates remain uncertain. Translational evidence ranges from small, uncontrolled senolytic and thymic-regeneration studies to randomized trials of mTOR inhibition and established efficacy of adjuvanted zoster vaccination. Negative trial findings and limitations of biomarker-based rejuvenation claims are considered. The central objective is to preserve protective immunity while reducing persistent inflammation; demonstrating durable improvements in clinical outcomes remains essential before experimental approaches can be regarded as immune rejuvenation therapies.

CellsVol. 15(22)
Intermountain Healthcare (US), South Texas College (US), University of Denver (US), Wesley Medical Center (US), Swedish Medical Center (US), IMMUNOe Research Center (US)
Good health and well-being
Telomeres, Telomerase, and Senescence
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon